You are here: Home / Pharmacology / Research / Overview / Publications archive

Publications: 1996

On this page:

Book chapters

  • Cooper EJ, Johnston GAR, Edwards FA (1996) Differential sensitivity during development of GABA-mediated synaptic transmission to a neuroactive steroid in rat hippocampus and cerebellum. In: GABA: Receptors, Transporters and Metabolism, *Tanaka C, *Bowery NG eds, Birkhauser Verlag, Basel, pp. 195-200
  • Liddle C, **Little JM (1996) Hydatid disease of the liver. In: Hepatobiliary and Pancreatic Disease: A Team Approach, *Carr-Locke D, *Ferrucci J, *Pitt HA eds, Little Brown and Co, 91-100
  • Seale JP (1996) Chronic obstructive pulmonary disease. In: MIMS Disease Index, *Speight TM ed., IMS Publishing, Sydney, 104-106
  • Shenfield GM (1996) Therapeutic drug monitoring: when is it of value? In: MIMS Disease Index, *Speight TM ed., IMS Publishing, Sydney, 502-506
Back to top

Refereed journal articles

  • Allan RD, Duke RK, **Hambley TW, Johnston GAR, Mewett KN, Quickert N, Tran HW (1996) Synthesis of unsaturated analogues of glutamic acid by amination of trianions from unsaturated dicarboxylic acids with chloramine, Australian Journal of Chemistry 49, 785-791
  • **Anticevich SZ, **Hughes JM, Black JL, **Armour CL (1996) Induction of hyperresponsiveness in human airway tissue by neutrophils: mechanism of action, Clinical and Experimental Allergy 26, 549-556
  • **Armour CL, McKay KO, Johnson PRA, Glanville AR, Black JL (1996) Does the disease state influence the responsiveness of human airways studied in vitro? Journal of Applied Physiology 80, 2211-2218
  • Atkin PA, **Ogle SJ, **Finnegan TP, Shenfield GM (1996) Influence of 'academic detailing' on prescribing for elderly patients, Health Promotion Journal of Australia6, 14-20
  • **Barter LS, Maddison JE, **Watson ADJ (1996) Comparison of methods to assess dog owners' therapeutic compliance, Australian Veterinary Journal 74, 443-446
  • **Barter LS, **Watson ADJ, Maddison JE (1996) Owner compliance with short-term antimicrobial medication in dogs, Australian Veterinary Journal 74, 277-280
  • Black JL (1996) Asthma, The Important Questions III: Role of airway smooth muscle, American Review of Respiratory and Critical Care Medicine 153, S2-S4
  • Boyle FM, *Wheeler HR, Shenfield GM :(1996) Glutamate ameliorates experimental vincristine neuropathy, Journal of Pharmacology and Therapeutics 279, 410-415
  • Brzuszczak IM, *Zhao J, *Bell C, *Stiel D, *Fielding I, *Percy J, *Smith R, *O'Loughlin EV (1996) Cyclic AMP-dependent anion secretion in human small and large intestine, Journal of Gastroenterology and Hepatology 11, 804-810
  • *Chan BSH, *Lazzaro VA, *Kirwan PD, Seale JP, Duggin GG (1996) The effect of paraquat on two renal epithelial cell lines: LLC-PK-1 and MDCK, Research Communications in Pharmacology and Toxicology 1, 99-112
  • *Chan BSH, *Lazzaro VA, Seale JP, Duggin GG (1996) Transport of paraquat in a renal epithelial cell line LLC-PK1, Journal of Pharmacology and Experimental Therapeutics, 279, 625-632
  • Chang D, Einstein R (1996) Changes in cardiovascular responsiveness to dopexamine and beta-1 and beta-2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs, Journal of Autonomic Pharmacology 16, 269-279
  • *Cheung NW, Liddle C, *Coverdale S, *Lou JC, *Boyages SC (1996) Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man, Journal of Clinical Endocrinology and Metabolism 81, 1999-2001
  • Chieng B, Christie MJ (1996) Local opioid withdrawal in rat single periaqueductal gray neurons in vitro, Journal of Neuroscience 16, 7128-7136
  • Chieng B, Connor MA, Christie MJ (1996) The ยต-opioid receptor antagonist D-phe-cys-tyr-D-trp-orn-thr-pen-thr-NH-2 (CTOP) [but not D-phe-cys-tyr-D-trp-arg-thr-pen-thr-NH-2 (CTAP)], produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons, Molecular Pharmacology 50, 650-655
  • Connor MA, *Henderson G (1996) delta and mu-Opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells, British Journal of Pharmacology 117, 333-340
  • Connor MA, **Vaughan CW, Chieng B, Christie MJ (1996) Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro, British Journal of Pharmacology 119, 1614-1618
  • Connor MA, *Yeo A, *Henderson G (1996) The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line, British Journal of Pharmacology 118, 205-207
  • Daviskas E, Anderson SD, *Gonda I, *Bailey D, *Bautovich G, Seale JP (1996) Mucociliary clearance during and after isocapnic hyperventilation with dry air in the presence of frusemide, European Respiratory Journal9, 716-724
  • Daviskas E, Anderson SD, *Gonda I, *Eberl S, *Meikle S, Seale JP, *Bautovich G (1996) Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects, European Respiratory Journal9, 725-732
  • Dodd PR, **Kril JJ, **Thomas GJ, Watson WEJ, Johnston GAR, **Harper CG (1996) Receptor binding sites and uptake activities mediating GABA neurotransmission in chronic alcoholics with Wernicke encephalopathy, Brain Research 710, 215-228
  • Gillies DM, Mylecharane EJ, *Jackson DM (1996) Effects of 5-HT-3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area, European Journal of Pharmacology 303, 1-12
  • Goodwin BJ, Liddle C, **Murray M, **Tapner M, *Rooney T, **Farrell GC (1996) Effects of metyrapone on expression of CYPs 2C11, 3A2 and other 3A genes in rat hepatocytes cultured on matrigel, Biochemical Pharmacology 52, 219-227
  • Greenwood JR, Vaccarella G, Capper HR, Mewett KN, Allan RD, Johnston GAR (1996) Theoretical studies on the free-radical bromination of methyl-pyridazines in the synthesis of novel heterocyclic analogues of neurotransmitters, Theochem-Journal of Molecular Structure 368, 235-243
  • Gross AS, Phillips AC, *Rieutord A, Shenfield GM (1996) The influence of the sparteine/debrisoquine genetic polymorphism on the disposition of dexfenfluramine, British Journal of Clinical Pharmacology 41, 311-317
  • **Grunstein RR, **Stewart DA, Lloyd HGE, Akinci M, Cheng N, **Sullivan CE (1996) Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones, Sleep 19, 774-782
  • Henderson JM, *Ghika JA, *Van Melle G, *Haller E, Einstein R (1996) Botulinum toxin in non-dystonic tremors, European Neurology 36, 29-35
  • **Hughes JM, **Sewell WP, Black JL, **Armour CL (1996) The effect of dexamethasone on expression of adhesion molecules on CD4+ lymphocytes, American Journal of Physiology 15, L79-L84
  • **Hughes JM, **Stringer RS, Black JL, **Armour CL (1996) The effects of tumour necrosis factor alpha on mediator release from human lung, Pulmonary Pharmacology 8, 31-36
  • Johnson PRA, McKay KO, **Armour CL, Black JL (1996) The maintenance of functional activity in human isolated bronchus after cryopreservation, Pulmonary Pharmacology 8, 43-48
  • Johnston GAR (1996) GABA-A receptor pharmacology, Pharmacology and Therapeutics 69, 173-198
  • Johnston GAR (1996) GABA-C receptors: relatively simple transmitter-gated ion channels? Trends in Pharmacological Sciences, 17, 319-323
  • Johnston GAR (1996) Small molecules as drugs, Chemistry in Australia 64, 212-213
  • *Kassiou M, Nguyen VH, *Knott R, Christie MJ, **Hambley T (1996) Trishomocubanes, a new class of selective and high affinity ligands for the sigma binding site, Bioorganic and Medicinal Chemistry Letters 6, 595-600
  • *Killinger S, **Blume GL, *Bohart L, *Bested A, *Dias LS, *Cooper B, Allan RD, **Balcar VJ (1996) Autoradiographic studies indicate regional variations in the characteristics of L-glutamate transporters in the rat brain, Neuroscience Letters 216, 101-104
  • Konnaris K, Lloyd HGE, Temple DM (1996) Release of adenosine from human sensitized lung fragments and its effect on antigen-induced mediator release, Pulmonary Pharmacology 9, 141-148
  • **Li YN, **Tattam B, **Brown KF, Seale JP (1996) Determination of epimers 22R and 22S of budesonide in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry, Journal of Chromatography B: Biomedical Applications 683, 259-268
  • Liddle C (1996) Hepatitis C, Anaesthesia and Intensive Care 24, 180-183
  • **Lin R, Liddle C, **Byth K, **Farrell GC (1996) Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C, Journal of Viral Hepatitis 3, 85-89
  • Maddalena DJ (1996) Applications of artificial neural networks to quantitative structure-activity relationships, Expert Opinion in Therapeutic Patents6, 239-251
  • Maddison JE, Mickelthwaite C, Watson WEJ, Johnston GAR (1996) Synaptosomal and brain slice cerebrocortical 3H-L-glutamate uptake in a rat model of hepatic encephalopathy, Neurochemistry International 28, 89-93
  • **McGill M, Donnelly R, **Molyneaux L, **Yue DK (1996) Ethnic differences in the prevalence of hypertension and proteinuria in NIDDM, Diabetes Research and Clinical Practice 33, 173-179
  • McKay KO, **Armour CL, Black JL (1996) Endothelin receptors and activity differ in human, dog and rabbit lung, American Journal of Physiology (Lung Cellular & Molecular Physiology) 14, L37-L43
  • *Morris AD, Donnelly R (1996) Angiotensin II: an insulin-sensitizing vasoactive hormone, Journal of Clinical Endocrinology 81, 1303-1306
  • Mylecharane EJ (1996) Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies, Behavioural Brain Research 73, 1-5
  • Nguyen VH, *Kassiou M, Johnston GAR, Christie MJ (1996) Comparison of binding parameters of sigma-1 and sigma-2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes, European Journal of Pharmacology311, 233-240
  • Osborne PB, Christie MJ (1996) Tetrahydro-9-aminoacridine has mixed actions on muscarinic currents and blocks opioid currents in rat locus coeruleus neurons, Journal of Pharmacology and Experimental Therapeutics 276, 137-142
  • Osborne PB, Vaughan CW, Wilson HI, Christie MJ (1996) Opioid inhibition of rat periaqueductal gray neurones with identified projections to rostral ventromedial medulla in vitro, Journal of Physiology (Lond.) 490, 383-389
  • Seale JP (1996) Careers in pharmacology: an Australian academic perspective, Trends in Pharmacological Sciences 17, 34-36
  • *Sullivan-Klose TH, *Ghanayem BI, *Bell DA, *Zhang Z-Y, *Kaminsky LS, Shenfield GM, *Miners JO, *Birkett DJ, *Goldstein JA (1996) The role of the CYP2C9-Leu-359 allelic variant in the tolbutamide polymorphism, Pharmacogenetics 6, 341-350
  • **Tapner M, Liddle C, Goodwin BJ, *George J, **Farrell GC (1996) Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes, Hepatology 24, 367-373
  • Vaughan CW, **Bandler R, Christie MJ (1996) Differential responses of lateral and ventrolateral rat periaqueductal grey neurones to noradrenaline in vitro, Journal of Physiology (Lond.) 490, 373-381
  • Vaughan CW, Christie MJ (1996) Increase by the ORL-1 receptor (opioid receptor-like 1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones, British Journal of Pharmacology 117, 1609-1611
  • *Weekes L, *Ho K, Seale JP (1996) Treatment of acromegaly: cost benefits, Pharmacoeconomics 10, 453-459
  • **Weltman MD, **Farrell GC, Liddle C (1996) Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation, Gastroenterology 111, 1645-1653
  • Yang KXF, Black JL (1996) Protein kinase C induced changes in human airway smooth muscle tone: the effects of Ca2+ and Na+ transport, European Journal of Pharmacology 315, 65-71
  • Yap BK, Kazlauskas R, *Elghazi K, Johnston GAR, Weatherby RP (1996) Profiling of urinary testosterone and luteinizing hormone in exercise-stressed male athletes using gas chromatography-mass spectrometry and enzyme immunoassay techniques, Journal of Chromatography B: Biomedical Applications 687, 117-125
Back to top

Other publications

  • Donnelly R (1996) Role of the beta-3 adrenoceptor in obesity and NIDDM (editorial), Medical Journal of Australia 165, 537-538
  • Donnelly R (1996) The beta-3 adrenoceptor: an advance in the understanding of obesity and insulin resistance, Medical Journal of Australia 165, 537-538
  • Hoskins J, Gross AS, Shenfield GM (1996) The new antidepressants, Australian Prescriber 19, 59
  • Johnston GAR (1996) Some thoughts on the Innovation Statement, Chemistry in Australia 63, 101-102
  • Kristoffersen SS, Atkin PA, Shenfield GM (1996) Uptake of alternative medicine, Lancet 347, 972
  • Maddison JE (1996) Delegates happy but exhausted after top-rating conference, Australian Veterinary Practitioner 26, 221-221
  • Maddison JE (1996) How to treat hepatic disease in cats, The Veterinarian, May 1996, 16-19
  • Maddison JE (1996) Adverse drug reactions: report of the Australian Veterinary Association Adverse Drug Reaction Subcommittee, 1994, Australian Veterinary Journal 73, 132-136
  • *Noller B, Johnston GAR (1996) The 1995 International Chemical Congress of Pacific Basin Societies, Chemistry in Australia 63, 180
  • Seale JP (1996) What's new in asthma management, Current Therapeutics July, 65-69
  • Shenfield GM (1996) Are all the sulphonylureas the same? Treating Diabetes 24, 9-17
  • Shenfield GM (1996) The new antidepressants, Australian Prescriber 19, 37-38
  • Seale JP (1996) Careers in pharmacology: an Australian academic perspective, Trends in Pharmacological Sciences 17, 34-36
  • *Spurling TH, Johnston GAR (1996) The chemical deficit, Chemistry in Australia 63, 191
Back to top

Patents registered

  • Compounds with steroid-like activity (Burden PM and Johnston GAR, 1996, Australian Patent Application No PN 8899)
Back to top

NOTE:
**Member of another department, University of Sydney
*Not a member of the University of Sydney